370 related articles for article (PubMed ID: 26697769)
1. Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice.
Giles JT
Best Pract Res Clin Rheumatol; 2015; 29(4-5):597-613. PubMed ID: 26697769
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
[TBL] [Abstract][Full Text] [Related]
3. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; Liem AH; van de Geijn GM; van der Meulen N; Birnie E; van der Zwan EM; van Zeben J; Castro Cabezas M
Ann Rheum Dis; 2019 Mar; 78(3):335-341. PubMed ID: 30610067
[TBL] [Abstract][Full Text] [Related]
4. Reducing the cardiovascular disease burden in rheumatoid arthritis.
Van Doornum S; Jennings GL; Wicks IP
Med J Aust; 2006 Mar; 184(6):287-90. PubMed ID: 16548834
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?
Giles JT
Curr Rheumatol Rep; 2016 May; 18(5):27. PubMed ID: 27032790
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cardiovascular disease in rheumatoid arthritis.
Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
[TBL] [Abstract][Full Text] [Related]
7. Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.
Chodara AM; Wattiaux A; Bartels CM
Curr Rheumatol Rep; 2017 Apr; 19(4):16. PubMed ID: 28361332
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk in rheumatoid arthritis.
Nurmohamed MT
Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.
Lim DT; Cannella AC; Michaud KD; Mikuls TR
Curr Rheumatol Rep; 2014 Nov; 16(11):459. PubMed ID: 25315196
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
Giollo A; Bissell LA; Buch MH
Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.
Carbone F; Bonaventura A; Liberale L; Paolino S; Torre F; Dallegri F; Montecucco F; Cutolo M
Clin Rev Allergy Immunol; 2020 Feb; 58(1):1-14. PubMed ID: 30259381
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis.
Ikdahl E; Rollefstad S; Wibetoe G; Olsen IC; Berg IJ; Hisdal J; Uhlig T; Haugeberg G; Kvien TK; Provan SA; Semb AG
J Rheumatol; 2016 Sep; 43(9):1622-30. PubMed ID: 27307523
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.
Semb AG; Ikdahl E; Wibetoe G; Crowson C; Rollefstad S
Nat Rev Rheumatol; 2020 Jul; 16(7):361-379. PubMed ID: 32494054
[TBL] [Abstract][Full Text] [Related]
14. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis.
Mahmoudi M; Aslani S; Fadaei R; Jamshidi AR
Int J Rheum Dis; 2017 Mar; 20(3):287-297. PubMed ID: 28205331
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors in inflammatory arthritis.
Mirjafari H; Al-Husain A; Bruce IN
Curr Opin Lipidol; 2011 Aug; 22(4):296-301. PubMed ID: 21670670
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and early detection of atherosclerosis in rheumatoid arthritis.
de Groot L; Posthumus MD; Kallenberg CG; Bijl M
Eur J Clin Invest; 2010 Sep; 40(9):835-42. PubMed ID: 20597966
[TBL] [Abstract][Full Text] [Related]
17. Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review.
Ghosh-Swaby OR; Kuriya B
Arthritis Res Ther; 2019 Jan; 21(1):33. PubMed ID: 30670075
[TBL] [Abstract][Full Text] [Related]
18. Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.
Chighizola C; Schioppo T; Ingegnoli F; Meroni PL
Curr Vasc Pharmacol; 2012 Sep; 10(5):639-46. PubMed ID: 22272912
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate & rheumatoid arthritis associated atherosclerosis: A narrative review of multidisciplinary approach for risk modification by the international board of experts.
Avagimyan A; Fogacci F; Pogosova N; Kakturskiy L; Jndoyan Z; Faggiano A; Bairamyan T; Agati L; Sattar Y; Mkrchyan L; Avetisyan G; Ginosyan K; Aznauryan A; Sahakyan K; Trofimenko A; Urazova O; Mikhaleva L; Vandysheva R; Kogan E; Demura T; Kc M; Shafie D; Nicola S; Brussino L; Cicero A; Biondi-Zoccai G; Sarrafzadegan N
Curr Probl Cardiol; 2024 Feb; 49(2):102230. PubMed ID: 38040221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]